Blood and cerebrospinal fluid biomarker changes in patients with hiv-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial

HIGHLIGHTS

• who: Lindokuhle Thela from the Mental Health, Institute, University South Africa have published the paper: Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial, in the Journal: (JOURNAL)
• what: The authors aimed to determine whether lithium can halt or reverse the injury caused by HIV in patients diagnosed with moderate to severe HAND who are on stable ART treatment. The object was more conservative, and the authors aimed for a GDS difference of 0.25 (versus 0.3). This study presents . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.